mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
0.9 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
0.9 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
1 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.018 |
1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |